CN1092655A - A kind of medicine for the treatment of hemorrhoid - Google Patents
A kind of medicine for the treatment of hemorrhoid Download PDFInfo
- Publication number
- CN1092655A CN1092655A CN 93110642 CN93110642A CN1092655A CN 1092655 A CN1092655 A CN 1092655A CN 93110642 CN93110642 CN 93110642 CN 93110642 A CN93110642 A CN 93110642A CN 1092655 A CN1092655 A CN 1092655A
- Authority
- CN
- China
- Prior art keywords
- medicine
- hemorrhoid
- treatment
- weight
- alumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of medicine for the treatment of hemorrhoid, this effective elements of the medicine comprises sodium citrate, Alumen, acetic acid.Its proportioning is preferably: sodium citrate 5-25 weight %, Alumen 2-20 weight %, acetic acid 2-20 weight %, surplus are carrier.This medicine reaches 97.44% to the internal hemorrhoid treatment total effective rate, and have that using dosage is little, pain is light, hemostasis is fast, cure time is short, clinical advantage such as easy to use.
Description
The present invention relates to a kind of medicine for the treatment of hemorrhoid, particularly be applicable to the medicine of treatment internal hemorrhoid.
Hemorrhoid are diseases of a kind of common pilosity, and the Therapeutic Method of employing is also more, and wherein Drug therapy is with injection drug curative effect the best.At present the injection drug of most common treatment is " xiaozhiling injection " of the development of Gate of Pervasive Peace hospital of Beijing academy of traditional Chinese medicine clinically, is 95.5% to the effective percentage of internal hemorrhoid treatment.But this medicine injection shot is big, needs 15-20ml, the patient suffering big and the time have complication to take place.
The object of the present invention is to provide a kind of therapeutic effect better, shot consumption is few, and the patient suffering is few and have no side effect and the medicine of the treatment hemorrhoid of complication.
The object of the present invention is achieved like this: this effective elements of the medicine comprises sodium citrate, Alumen, acetic acid.
Its proportioning is preferably: sodium citrate 5-25 weight %, Alumen 2-20 weight %, acetic acid 2-20 weight %, carrier are made injection type with water the best.When carrier is oil or vaseline, also can be made into putty-type.
Injecting drug use of the present invention is a colourless transparent solution, during treatment medicine is directly injected blood stasis tela submucosa, and the blood stasis atrophy is come off, and consumption can be grasped according to the blood stasis size, and generally each blood stasis dosage only needs 0.2-0.5ml to get final product.
Through clinical practice and processing by statistics, show that this medicine can reach 100% to the cure rate of initial stage internal hemorrhoid, total effective rate reaches 97.44%, is better than " xiaozhiling injection " and other medicines.Only need a pin to stop blooding to Internal hemorrhoid hemorrhage.
Because active ingredient of the present invention is all nontoxic, non-stimulated, and use amount 0.2-0.5ml only, so patient is painful few, the 5-10 hypodynia of second is only arranged after the injection, and without any side effects and complication generation.Use also easyly, patient only can fully recover with a door rash several times, need not to be in hospital.
Embodiment 1
Sodium citrate 15 grams, Alumen 50 grams, adding distil water 500ml, heating for dissolving adds 36% acetic acid 200ml, is settled to 1000ml with distilled water, and the ampoule bottle of packing into is made every bottle of 0.5ml injection.
Claims (3)
1, a kind of medicine for the treatment of hemorrhoid is characterized in that this effective elements of the medicine comprises sodium citrate, Alumen, acetic acid.
2, according to the medicine of the described treatment hemorrhoid of claim 1, it is characterized in that the proportioning of this medicine is: sodium citrate 5-25 weight %, Alumen 2-20 weight %, acetic acid 2-20 weight %, surplus are carrier
3, according to the medicine of the described treatment hemorrhoid of claim 2, it is characterized in that: the carrier of this medicine is a water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93110642 CN1058154C (en) | 1993-03-27 | 1993-03-27 | Medicine for treatment of pile |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93110642 CN1058154C (en) | 1993-03-27 | 1993-03-27 | Medicine for treatment of pile |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1092655A true CN1092655A (en) | 1994-09-28 |
| CN1058154C CN1058154C (en) | 2000-11-08 |
Family
ID=4988485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93110642 Expired - Fee Related CN1058154C (en) | 1993-03-27 | 1993-03-27 | Medicine for treatment of pile |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058154C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997018820A1 (en) * | 1995-11-21 | 1997-05-29 | Chuyakuken, Ltd. | External preparation for curing lesioned tissues |
| WO1997030711A1 (en) * | 1996-02-23 | 1997-08-28 | Chuyakuken, Ltd. | External preparation for curing lesioned tissues |
| CN1067569C (en) * | 1997-11-12 | 2001-06-27 | 内蒙古医学院 | Zhixuening-medicine for stopping bleeding |
| CN112494497A (en) * | 2020-12-22 | 2021-03-16 | 唐凌文 | Compound liquid preparation and preparation method and application thereof |
-
1993
- 1993-03-27 CN CN 93110642 patent/CN1058154C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997018820A1 (en) * | 1995-11-21 | 1997-05-29 | Chuyakuken, Ltd. | External preparation for curing lesioned tissues |
| WO1997030711A1 (en) * | 1996-02-23 | 1997-08-28 | Chuyakuken, Ltd. | External preparation for curing lesioned tissues |
| CN1067569C (en) * | 1997-11-12 | 2001-06-27 | 内蒙古医学院 | Zhixuening-medicine for stopping bleeding |
| CN112494497A (en) * | 2020-12-22 | 2021-03-16 | 唐凌文 | Compound liquid preparation and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1058154C (en) | 2000-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG65417B1 (en) | Application of eritropoetin or eritropoetin derivatives for the treatment of cerebral ischaemia | |
| KR20080031394A (en) | Pharmaceutical compositions comprising a tgf-beta superfamily member | |
| McKinney et al. | Reversal of severe tricyclic antidepressant-induced cardiotoxicity with intravenous hypertonic saline solution | |
| CN1141929C (en) | Medicament and method of treating an organism with medicaments | |
| CN1058154C (en) | Medicine for treatment of pile | |
| JPH08512311A (en) | Arsenic medicine for treating chronic fatigue syndrome | |
| US6623732B1 (en) | Pharmaceutical formulation for nasal administration | |
| RU2009116629A (en) | Azithromycin for the treatment of nodular acne | |
| CN1068227C (en) | Interferon liposome jellies | |
| Godlowski | Stimulation of the Suprarenal Glands in the Treatment of Rheumatoid Arthritis: Preliminary Report | |
| RU1803119C (en) | Method of extrauterine pregnancy treatment | |
| CN1050994C (en) | Enteroclysis medicine Liq.-Acidum pipemidicum syrup for curing diarrhea | |
| SU1706624A1 (en) | Method for curing opiumism and morphinism | |
| RU2070030C1 (en) | Method of treatment of maxillofacial region inflammatory disease in patients with diabetes mellitus | |
| CN1287776C (en) | Process for preparing houttuyninum sodium injection | |
| Hartmann et al. | Unanticipated side effects from treatment with high dose mechlorethamine in patients with malignant melanoma | |
| CN1117563C (en) | Analgesic composition for cancers in digestive system | |
| CN1045720C (en) | Injection preparated with Taihe chicken bile for treating cataract | |
| Watson | Effects of concurrent drug therapy and of feeding on plasma chloramphenicol levels after oral administration of chloramphenicol in dogs | |
| JPS6237017B2 (en) | ||
| RU2258520C2 (en) | Method for treating stem ischemic insult | |
| RU2016576C1 (en) | Method of preventing allergic reactions in effecting parenteral therapy | |
| CN1131541A (en) | Western medicine compound for fever abatement | |
| CN116327746A (en) | Application of isoliquiritigenin in preparation of medicine for preventing or treating drug-induced liver injury caused by acetaminophen | |
| RU2195299C2 (en) | Method of treating psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |